Fluorocarbon emulsions

Clark L. , Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152: 1755-56.

Gollan F. , Clark LC Organ perfusion with fluorocarbon fluid. Physiologist 1966; 9: 191.

Sloviter HA , Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967; 216: 458-60.

Sloviter HA , Petkovic M. , Ogoshi S. , Yamada H. Dispersed fluorochemicals as substitutes for erythrocytes in intact animals . J Appl Phys 1969; 27(5): 666-68.

Geyer RP , Taylor K. , Duffett EB , Eccles R. Successful complete replacement of the blood of living rats with artificial substitutes. Fed Proc 1973; 32: 927.

Geyer RP Fluorocarbon-polyol artificial blood substitutes. N Engl J Med 1973; 289: 1077-82.

Clark LC , Kaplan S. , Becattini F. The physiology of synthetic blood. J Thorac Cardiovasc Surg 1970; 60(6): 757-73.

Clark LC , Wesseler EP , Kaplan S. et al. Emulsions of perfluorinated solvents for intravascular gas transport . Fed Proc 1975; 34(6): 1468-77.

Ohyanagi H. , Sekita M. , Yokoyama K. et al. Fourth International Symposium on Perfluorochemical Blood Substitutes , Kyoto, Japan. Amsterdam: Excerptica Medica, 1978; 373-89.

Mitsuno T. , Ohyanagi H. Present status of clinical studies of Fluosol-DA (20%) in Japan. In: Tremper K ed. Perfluorochemical oxygen transport. International Anesthesiology Clinics, Volume 23. Boston : Little, Brown and Company, 1985 : 169-84.

Gould SA , Rosen AL , Sehgal LR et al. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 1986; 314(26): 1653-56.

Spence RK , McCoy S. , Costabile J. et al. Fluosol DA-20 in the treatment of severe anemia: randomised, controlled study of 46 patients. Crit Care Med 1990; 18(11): 1227-30.

Vercelotti GM , Hammerschmidt DE , Craddock PR , Jacob HS Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis . Blood 1982; 59(6): 1299-304.

Ingram DA , Forman MB , Murray JJ Activation of complement by Fluosol attributable to the pluronic detergent micelle structure. J Cardiovasc Pharmac 1993 ; 22(3): 456-61.

Hammerschmidt DE , Vercelotti GM Limitation of complement activation by perfluorocarbon emulsions. Superiority of lecithin-emulsified preparations. In: Chang TMS , Geyer RP eds. Blood substitutes. New York: Marcel Dekker Inc, 1988: 431-38.

Breuninger HG , Rubenstein SD , Wolfson MR , Shaffer TH Effect of exchange transfusion with a red blood cell substitute on neonatal haemodynamics and organ blood flows. J Pediatr Surg 1993; 28(2): 144-50.

Mattrey RF , Hilpert PL , Long CD , Long DM , Mitten RM , Peterson T. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit Care Med 1989; 17(7): 652-56.

Meinert H. , Fackler R. , Knoblich A. , Mader J. , Reuter P. , Rohlke W. On the perfluorocarbon emulsions of second generation. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 805-18.

Mahe AM , Manoux J. , Valla A. et al. Perfluoroalkylated surfactants: relationships between structure and acute toxicity in mice. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 1025-27.

Riess JG Fluorocarbon-based in vivo oxygen transport and delivery systems. Vox Sanguinis 1991; 61(4): 225-39.

Faithfull NS Second generation fluorocarbons. In: Erdmann W , Bruley DF eds. Oxygen transport to tissue XIV. Advances in experimental medicine and biology, volume 317. New York: Plenum Press, 1992:441-52.

Mattrey RF Perfluorooctylbromide: a new contrast agent for CT, sonography and MR imaging . Am J Roentgenol 1989; 152: 247-52.

Riess JG Fluorocarbon-based oxygen carriers: new orientations. Artif Organs 1991; 15(5): 408-13.

Lowe KC Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology. Vox Sanguinis 1991 ; 60(3): 129-40.

Tremper KK , Cullen BF US clinical studies of the treatment of anemia with Fluosol-DA 20 % Artif Organs 1984; 8(1): 19-24.

Tremper KK , Levine EM , Waxman K. Clinical experience with Fluosol-DA (20%) in the United States. In: Tremper KK ed. Perfluorochemical oxygen transport. International Anesthesiology Clinics, volume 23. Boston: Little, Brown and Company , 1985: 185-197.

Braun RD , Linsenmeier RA , Goldstick TK New perfluorocarbon emulsion improves tissue oxygenation in cat retina . JAppl Phys 1992; 72(5): 1960-68.

Hogan MC , Willford DC , Keipert PE , Faithfull NS , Wagner PD Increased plasma O2 solubility improves O2 uptake of in situ dog muscle working maximally. J Appl Phys 1992; 73(6): 2470-75.

Bentley PK , Johnson OL , Washington C. , Lowe KC Uptake of concentrated perfluorocarbon emulsions into rat lymphoid tissues . J Pharm Pharmacol 1993; 45(3): 182-85.

Meyer KL , Carvlin MJ , Mukherji B. , Sloviter HA , Joseph PM Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging. Invest Radiol 1992; 27(8): 620-27.

Pfannkuch F. , Schnoy N. Long term observation of PFC storage in organs of rats after various dosages . In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New York : Alan R Liss Inc, 1983: 209-19.

Waxman K. , Temper KK , Cullen BF , Mason GR Perfluorocarbon infusion in bleeding patients refusing blood transfusions . Arch Surg 1984; 119: 721-24.

Faithfull NS Fluorocarbons: current status and future applications . Anaesthesia 1987; 42: 234-42.

Yokoyama K. , Yamanouchi K. , Murashima R. Excretion of perfluorochemicals after intravenous injection of their emulsion. Chem Pharmacol Bull 1975 ; 23(6): 1368-73.

Faithfull NS Artificial oxygen carrying blood — substitutes . In: Erdmann W , Bruley DF eds. Oxygen transport to tissue XIV. Advances in Experimental Medicine and Biology, Volume 317. New York : Plenum Press, 1992: 55-72.

Reiss JG Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships . Artif Organs 1984; 8(1): 44-56.

Lutz J. , Metzenauer P. Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen. Pflü Arch 1980; 387: 175-81.

Kaufman RJ Medical oxygen transport using perfluorochemicals. Biotechnology 1991; 19: 127-62.

Vercelotti GM , Hammerschmidt DE Human studies including perfluorochemical emulsions. In: Lowe KC ed. Blood substitutes: preparation, physiology and medical applications. Chichester, England: Ellis Horwood, 1988: 173-83.

Honda K. , Hoshino S. , Shoji M. et al. Clinical use of a blood substitute. New Engl J Med 1980; 303(7): 391-92.

Makowski H. , Tentshev P. , Frey R. , Necek S. , Bergmann H. , Blauhut B. Tolerance of an oxygen carrying colloidal plasma substitute in humans . Fourth International Symposium on Perfluorochemical Blood Substitutes , Kyoto, Japan. Amsterdam: Excerptica Medica, 1978 : 47-54.

Stefaniszyn HJ , Wynands JE , Salerno TA Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients. J Cardiovasc Surg 1985; 26: 337-42.

Waxman K. , Cheung CK , Mason GR Hypotensive reaction after infusion of a perfluorochemical emulsion . Crit Care Med 1984; 12(7): 609-10.

Tremper KK , Vercelotti GM , Hammerschmidt DE Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20% . Crit Care Med 1984; 12(5): 428-31.

Hong F. , Shastri KA , Logue GL , Spauldin MB Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies. Transfusion 1991; 31(7): 642-47.

Peck WW , Mattrey RF , Slutsky RA , Higgins CB Perfluorooctyl bromide: acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media. Investig Radiol 1984;19(2): 129-32.

Bottalico LA , Betensky HT , Min YB , Weinstock SB Perfluorochemical emulsions decrease Kupffer cell phagocytosis. Hepatology 1991; 14(1): 169-74.

Fujita T. , Suzuki C. , Ogawa R. Effect of Fluosol-DA on the reticuloendothelial system function in surgical patients. In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in Blood Substitute Research. Progress in Clinical and Biological Research, Volume 122. New York: Alan R Liss Inc, 1983: 265.

Police AM , Waxman K. , Tominaga G. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss. Crit Care Med 1985; 13(2): 96-98.

Ingram DA , Forman MB , Murray JJ Phagocytic activation of human neutrophils by the detergent component of fluosol . Am J Pathol 1992; 140(5): 1081-87.

Forman MB , Pitarys CJ II, Vildibill HD et al. Pharmacological perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion . JAm Coll Cardiol 1992; 19(1): 205-16.

Babbitt DG , Forman MB , Jones R. , Bajaj AK , Hoover RL Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical . Am J Pathol 1990; 136(2): 451-59.

Bentley PK , Davis SS , Johnson OL , Lowe KC , Washington C. Purification of Pluronic F-68 for perfluorochemical emulsification . J Pharm Pharmacol 1989; 41: 661-63.

Hammerschmidt DE , Vercellotti GM Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations . In: Chang TMS , Geyer RP eds. Blood substitutes. New York: Marcel Dekker Inc, 1989; 431-38.

Smith DJ , Lane TA Effect of a high concentration perfluorocarbon emulsion on platelet function . Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 1045-49.

Mattrey RF , Strich G. , Shelton RE et al. Perfluorochemicals as US contrast agents for tumour imaging and hepatosplenography: preliminary clinical results. Radiology 1987; 163: 339-43.

Shrewsbury RP Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs. Res Commun Chem Path Pharmacol 1987; 55: 375-96.

Ravis WR , Ramakanth S. , Brzozowski DM , Hamrick ME Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system. J Pharm Pharmacol 1992; 44(3): 219-23.

Shrewsbury RP , White LG Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit. Clinica Chimica Acta 1989 ; 179: 347-48.

Parsons DL , Ravis WR , Clark CR Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute. Archives Internationales de Pharmacodynamie et de Therapie 1985;277:4-14.

Parsons DL , Sathe RS Salicylate binding by human albumin in the presence of a perfluorochemical emulsion. Archives Internationales de Pharmacodynamie et de Therapie 1991; 310: 5-12.

Mitsuno T. , Ohyanagi H. , Naito R. Clinical studies of a perfluorochemical whole blood substitue (Fluosol F-DA): summary of 186 cases. Ann Surg 1982 ; 195(1): 60-69.

Chen H-S. , Yang Z-H. et al. Perfluorocarbon as blood substitute in clinical applications and in war casualties. In: Chang TMS ed. Blood substitutes. New York: Marcel Dekker Inc, 1989: 403-409.

Tremper KK , Friedman AE , Levine EM , Lapin R. , Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 1982; 307(5): 77-83.

Karn KE , Ogburn PL , Julian T. , Cerra FB , Hammerschmidt DE , Vercelotti G. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage. Obstet Gynae 1985; 65(1): 127-30.

Spence RK , McCoy S. , Costabile J. et al. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 1069.

Elliott LA , Ledgerwood AM , Lucas CE , McCoy LE , McGonigal M. , Sullivan MW Role of Fluosol-DA 20% in prehospital resuscitation. Crit Care Med 1989; 17(2): 166-72.

Atabek U. , Spence RK , Pello M. , Alexander J. , Camishion R. Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. Arch Surg 1992; 127(3): 349-51.

Spears JR , Serur J. , Baim DS , Grossman W. , Paulin S. Myocardial protection with Fluosol-DA during prolonged coronary balloon occlusion in the dog. Circulation 1983; 68(suppl III): 317.

Virmani R. , Kolodgie FD , Osmialowski A. , Zimmerman P. , Mergner W. , Forman MB Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion. Am Heart J 1988; 116(2 Part 1): 421-30.

Roberts CS , Anderson HV , Carboni Aaj et al. Usefulness of intracoronary infusion of fluorocarbon distal to prolonged coronary occlusion by angioplasty balloon in dogs. Am J Cardiol 1986; 57: 1202-205.

Christensen CW , Reeves WC , Lassar TA , Schmidt DH Inadequate subendocardial oxygen delivery during perfluorocarbon perfusion in a canine model of ischemia . Am Heart J 1988; 115(1): 30-37.

Robalino BD , Marwick T. , Lafont A. , Vaska K. , Whitlow PL Protection against ischaemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol. JAm Coll of Cardiol 1992 ; 20(6): 1378-84.

Kerins DM Role of the perfluorocarbon Fluosol-DA in coronary angioplasty. Am J Med Sci 1994; 307(3): 218-21.

Lincoff AM , Popma JJ , Ellis SG , Vogel RA , Topol EJ Percutaneous support devices for high risk or complicated coronary angioplasty . J Am Coll Cardiol 1991 ; 17(3): 770-80.

Anderson HV , Leimgruber PP , Ruobin GS , Nelson DL , Gruentzig AR Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty. Am Heart J 1985; 110(4): 720-26.

Young LH , Jaffe CC , Revkin JH , McNulty PH , Cleman M. Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. Am J Cardiol 1990; 65: 986-90.

Cleman M. , Jaffe CC , Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol-DA 20%. Circulation 1986; 74(3): 555-62.

Cowley MJ , Snow FR , DiSciascio G. , Kelly K. , Guard C. , Nixon JV Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients. Circulation 1990; 81(3 suppl IV): IV27-34.

Jaffe CC , Wohlgelernter D. , Cabin H. et al. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%. Am Heart J 1988 ; 115(6): 1156-64.

Kent KM , Cleman MW , Cowley MJ et al. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Am J Cardiol 1990; 66: 279-84.

Bell MR , Nishimura RA , Holmes DR Jr , Bailey KR , Schwartz RS , Vlietstra RE Does intracoronary infusion of Fluosol-DA20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty? J Am Coll Cardiol 1990; 16(4): 959-66.

Dill DB , Forbes WH Respiratory and metabolic effects of hypothermia. Am J Physiol 1941; 132: 685.

Kanter KR , Gardner TJ The use of perfluorochemicals during open heart surgery. In: Tremper KK ed. Perfluorochemical oxygen transport. International Anesthesiology Clinics, Volume 23. Boston : Little, Brown and Company, 1985 : 105-14.

Jaffin JH , Magovern Gjj , Kanter KR , Flaherty JT , Gardner TJ , Jacobus WE Improved myocardial metabolism with oxygenated perfluorocarbon cardioplegia . Surgical Forum 1981 ; 13: 290-93.

Magovern GJ , Flaherty JT , Gott VL , Bulkley BH , Gardner TJ Optimal myocardial protection with Fluosol cardioplegia. Ann Thorac Surg 1982; 34(3): 249-57.

Flaherty JT , Jaffin JH , Magovern Gjj et al. Maintenance of aerobic metabolism during global ischemia with perfluorocarbon cardioplegia improves myocardial preservation. Circulation 1984; 69(3): 585-92.

Novick RJ , Stefaniszyn HJ , Michel RP , Burdon FD , Salerno TA Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood and Fluosol-DA cardioplegia during prolonged aortic clamping. J Thorac Cardiovasc Surg 1985; 89(4): 547-66.

Cusimano RJ , Ashe KA , Chin ID et al. Myocardial protection in the hypertrophied right ventricle. Ann Thorac Surg 1991; 52(4): 934-38.

Harjula A. , Mattila S. , Salmenpera M. et al. Perfluorocarbon solution as a myocardial preservative. J Appl Cardiol 1987; 2(2): 121-36.

Rousou JA , Engelman RM , Anisimowicz L. et al. Metabolic enhancement of myocardial preservation during cardioplegic arrest. J Thorac Cardiovasc Surg 1986; 91(2): 270-76.

Harjula A. , Mattila S. , Salmenpera M. et al. Effect of addition of magnesium to potassium-containing fluorocarbon cardioplegic solutions. J Cardiovasc Surg 1987; 28(5): 566-70.

Tabayashi K. , McKeown PP , Miyamoto M. et al. Ischemic myocardial protection: comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions. J Thorac Cardiovasc Surg 1988; 95(2): 239-46.

Pearl JM , Laks H. , Drinkwater DC et al. Fluosol cardioplegia results in complete functional recovery: a comparison with blood cardioplegia. Ann Thorac Surg 1992; 54(6): 1144-50.

Acar C. , Partington MT , Buckberg GD Studies of controlled reperfusion after ischaemia. XIX. Reperfusate composition: benefits of blood cardioplegia over Fluosol DA cardioplegia during regional reperfusion-importance of including blood components in the initial reperfusate . J Thorac Cardiovasc Surg 1991 ; 101(2): 284-93.

Johnson DL , Greene PS , Gott VL , Gardner TJ New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation . Circulation 1988; 78(suppl III): 153-57.

Menasche P. , Grousset C. , Mouas C. , Moore RE , Piwnica A. Enhancement of cardioplegic protection with a lecithin-based perfluoroadamantane emulsion. In: Chang TMS ed. Blood substitutes. New York: Marcel Dekker, 1989: 607-18.

Hemmer W. , Guilliard P. , Triefenbach R. et al. Oxygenation of Bretschneider's HTK Solution with perfluorocarbon emulsions-high energy phosphates, ultrastructure, free oxygen radicals. Thorac Cardiovasc Surg 1993; 41(suppl 1): 150.

Glogar DH , Kloner RA , Muller J. , DeBoer Lwv , Braunwald E. Fluorocarbons reduce myocardial ischaemic damage after coronary occlusion . Science 1981; 211: 1439-41.

Nunn GR , Dunn G. , Peters J. , Cohn LH Effect of fluorocarbon exchange transfusion on myocardial infarct size in dogs. Am J Cardiol 1983; 52: 203-205.

Faithfull NS , Erdmann W. , Fennema M. , Kok A. Effects of haemodilution with fluorocarbons or dextran on oxygen tensions in the acutely ischaemic myocardium. Brit J Anaesth 1986; 58: 1031-40.

Faithfull NS , Fennema M. , Erdmann W. Protection against myocardial ischaemia by prior haemodilution with fluorocarbon emulsions. Brit J Anaesth 1988; 60: 773-78.

Rude RE , Bush LR , Tilton GD Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics. Am J Cardiol 1984; 54: 880-83.

Menasche P. , Fauchet M. , Lavergne A. et al. Applications of a perfluorocarbon to heart ischemia. In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New York : Alan R Liss Inc, 1983: 363-72.

Menasche P. , Escorsin M. , Birkui P. et al. Limitations of fluorocarbons in reducing myocardial infarct size. Am J Cardiol 1985 ; 55: 830-34.

Forman MB , Virmani R. , Puett DW Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990; 81(3 suppl IV): IV69-78.

Forman MB , Ingram DA , Murray JJ Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury. Am Heart J 1992; 124(5): 1347-57.

Forman MB , Bingham S. , Kopelman HA et al. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1985; 71(5): 1060-68.

Forman MB , Puett DW , Bingham SE et al. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1987; 76(2): 469-79.

Kolodgie FD , Dawson AK , Roden DM , Forman MB , Virmani R. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia. Am Heart J 1986; 112(6): 1192-201.

Bajaj AK , Cobb MA , Virmani R. , Gay JC , Light RT , Forman MB Limitation of myocardial reperfusion injury by intravenous perfluorochemicals . Circulation 1989; 79(3): 645-56.

Schaer GL , Karas SP , Santoian EC , Gold C. , Visner MS , Virmani R. Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction. J Am Coll Cardiol 1990 ; 15(6): 1385-93.

Kolodgie FD , Farb A. , Carlson GC , Wilson PS , Virmani R. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (Poloxamer 188) in a poorly collateralized animal model. J Am Coll Cardiol 1994; 24(4): 1098-108.

Rice HE , Virmani R. , Hart CL , Kolodgie FD , Farb A. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA. Am Heart J 1990; 120(5): 1039-46.

Kolodgie FD , Virmani R. , Farb A. , Hart CL Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA20%). J Am Coll Cardiol 1991; 18(1): 215-23.

Mohan C. , Gennaro M. , Marini C. , Ascer E. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon. Am J Surg 1992; 164(3): 194-98.

Ueda K. , Genda T. , Hirata I. et al. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart. J Heart Lung Transplantation 1992; 11(4 Part I): 646-55.

Martin SM , Laks H. , Drinkwater DC et al. Perfluorochemical reperfusion yields improved myocardial recovery after global ischaemia. Ann Thorac Surg 1993 ; 55(4): 954-60.

Forman MB , Perry JM , Wilson BH et al. Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction. J Am Coll Cardiol 1991;18(4):911-918.

Wall TC , Califf RM , Blankenship J. et al. Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial . Circulation 1994; 90(1): 114-20.

Tsai AG , Nolte D. , Messmer K. , Intaglietta M. Effect of Oyxgent (perflubron emulsion) on leukocyte-endothelial interaction in postcapillary venules. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 959-61.

Zenati M. , Yousen SA , Dowling RD Primary graft failure following preliminary transplantation. Transplantation 1990; 50: 165-67.

Yacoub M. , Mankad P. , Ledingham S. Donor procurement and surgical techniques for cardiac transplantation. Sem Thorac Cardiovasc Surg 1990; 2(2): 153-61.

Segel LD , Ensunsa JL , Boyle Wai. Prolonged support of working rabbit hearts using Fluosol-43 or erythrocyte media. Am J Physiol 1987; 252: H349-59.

Segel LD , Boyle Wai. Prolonged perfusion of isolated working rabbit hearts with a perfluorochemical emulsion. In: Chang TMS ed. Blood substitutes. New York: Marcel Dekker Inc, 1989: 619-21.

Silber R. , Sauer B. , Eigel P. , Henrich HA , Elert O. Electron microscopic changes and edema after nine hours' perfusion of isolated canine hearts. Heart Vessels 1991 ; 6(4): 203-10.

Baba S. , Nakai KK Ex-vivo perfusion of surgically removed organs. In: Chang TMS , ed. Blood substitutes. New York: Marcel Dekker Inc, 1989 : 623-24.

Berkowitz HD , McCombs P. , Sheety S. , Miller LD , Sloviter H. Fluorochemical perfusates for renal preservation . J Surg Res 1976; 20(6): 595-600.

Voiglio EJ , Cloix P. , Zarif L. , Gorry F. , Riess J. , Dubernard JM Ex vivo normothermic preservation of rat multiple organ blocks using a perfluorooctyl bromide emulsion as oxygen carrier. Transplant Proc 1993; 25(4):2558-60.

Bando K. , Teramoto S. , Tago M. , Teraoka H. , Seno S. , Senoo Y. Successful extended hypothermic cardiopulmonary preservation for heart-lung transplantation. J Thorac Cardiovasc Surg 1989; 98(1): 137-46.

Bando K. , Tago M. , Teramoto S. Prevention of free radical-induced myocardial injury by allopurinol. Experimental study in cardiac preservation and transplantation. J Thorac Cardiovasc Surg 1988; 95: 465-73.

Gohra H. , Mori F. , Esato K. The effect of fluorocarbon emulsion on 24-hour canine heart preservation by coronary perfusion. Ann Thorac Surg 1989 ; 48: 96-103.

Segel LD , Ensunsa JL Albumin improves stability and longevity of perfluorochemical-perfused hearts . Am J Physiol 1988; 254: H1105-12.

Segel LD , Minten Jmo , Schweighardt FK Fluorochemical emulsion APE-LM substantially improves cardiac preservation . Am J Physiol 1992; 263(3 Part 2): H730-39.

Bolling SF , Flaherty JT , Bulkley BH , Gott VL , Gardner TJ Improved myocardial preservation during global ischemia by continuous retrograde coronary sinus perfusion. J Thorac Cardiovasc Surg 1983; 86(5): 659-66.

Suzuki S. , Sasaki H. , Tomita E. et al. Twenty-four hour preservation of canine hearts by retrograde coronary sinus perfusion. Heart Transplantation 1984; 4(1): 76-80.

Kioka Y. , Tago M. , Bando K. et al. Twenty-four-hour isolated heart preservation by perfusion method with oxygenated solution containing perfluorochemicals and albumin. J Heart Transplantation 1986; 5(6): 437-43.

Segel LD , Follette DM , Iguidbashian JP et al. Posttransplantation function of hearts preserved with fluorochemical emulsion. J Heart Lung Transplantation 1994 ; 13(4): 669-80.

Urushihara T. , Sumimoto K. , Ikeda M. et al. A comparison study of rat pancreas preservation using perfluorochemical and fluorocarbon-emulsion as preservation medium. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 933-37.

Peerless SJ The use of perfluorochemicals in the treatment of acute cerebral ischemia . In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New York: Alan R Liss Inc, 1983: 353-62.

Peerless SJ , Nakamura R. , Rodriguez-Salazar A. , Hunter IG Modification of cerebral ischaemia with Fluosol. Stroke 1985 ; 16(1): 38-43.

Kolluri S. , Heros RC , Hedley-White ET , Vonsattel JP , Miller D. , Zervas NT Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischaemia. Stroke 1986; 17(5): 976-80.

Tranmer BI , Iacobacci R. , Feiler S. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability, and computerized EEG data during cerebral ischaemia. Neurolog Res 1990; 12(1): 17-22.

Kline RA , Negendank W. , McCoy L. , Berguer R. Beneficial effect of isovolemic hemodilution using a perfluorocarbon emulsion in a stroke model. Am J Surg 1991 ; 162(2): 103-106.

Kline RA , Negendank W. , McCoy LE Treatment of cerebral ischaemia with Dextran-40 or Fluosol DA 20% . Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 979-83.

Suzuki J. , Yoshimoto T. , Ogawa A. A new therapy for acute brain infarction: Revascularisation following the administration of mannitol and perfluorochemicals. In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New York: Alan R Liss Inc, 1983: 321-25.

Swann KW , Ropper AH , Zervas NT Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia. In: Bolin RB , Geyer R , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New York: Alan R Liss Inc, 1983: 399-404.

DelRossi AJ , Cernaianu AC , Cilley Jr JH et al. Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. J Thorac Cardiovasc Surg 1990; 99(4): 665-69.

Maughan RE , Mohan C. , Nathan IM et al. Intrathecal perfusion of an oxygenated perfluorocarbon prevents paraplegia after aortic occlusion . Ann Thorac Surg 1992; 54(5): 818-25.

Floyd TF , Boroughs A. , Garvey C. et al. Intestinal ischaemia: treatment by peritoneal lavage with oxygenated perfluorochemical. J Pediatr Surg 1987; 22(12): 1191-97.

Ricci JL , Sloviter HA , Ziegler MM Intestinal ischaemia: reduction of mortality using intraluminal perfluorochemical . Am J Surg 1985; 149: 84-90.

Hymes AC , Beck K. A comparison of Pluronic F-68, low molecular weight dextran, mannitol and saline as priming agents in the heart-lung apparatus. Part II. The in vitro influence on oxygen consumption of certain fluids used as priming agents in a heart-lung bypass apparatus. J Thorac Cardiovasc Surg 1968; 56: 23-27.

Engelman RM , Rousou JH , Dobbs WA Fluosol-DA: an artificial blood for total cardiopulmonary bypass. Ann Thorac Surg 1981 ; 32(6): 528-35.

Engelman RM , Dobbs WA , Roudou JH Use of Fluosol-DA during open-heart surgery. In: Bolin RB , Geyer RP , Nemo GJ eds. Advances in blood substitute research. Progress in Clinical and Biological Research, Volume 122. New Yofk: Alan R Liss Inc, 1983: 273-82.

Howlett S. , Dundas D. , Sabiston Dcj. Fluid fluorocarbon as oxygenator in experimental extracorporeal circulation. Arch Surg 1965 ; 91: 643-45.

Wallace HP , Stein TP , Asher WJ Evaluation of fluorochemicals for liquid membrane oxygenation. Fed Proc 1975; 34(6): 1506-509.

Sueda T. , Fukunaga S. , Matsuura Y. , Kajihara H. Evaluation of two new liquid-liquid oxygenators. ASAIO J 1993; 39(4): 923-28.

Sueda T. , Fukunaga S. , Mitsui N. , Matsuura Y. Development of an air lift pump oxygenator. ASAIO J 1993; 39(3): M725-28.

Jacobs HC , Mercurio MR Perfluorocarbons in the treatment of respiratory distress syndrome . Semin Perinatol 1993; 17(4): 295-302.

Moskowitz GD A mechanical respirator for control of liquid breathing. Fed Proc 1970; 29(5): 1751-754.

Fuhrman BP Perfluorocarbon liquid ventilation: the first human trial. J Pediatr 1990; 117(1): 73-74.

Curtis SE , Fuhrman BP , Howland DF , De Francisis M. , Motoyama EK Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets . Crit Care Med 1991; 19(2): 225-30.

Greenspan JS , Wolfson MR , Rubenstein SD , Shaffer TH Liquid ventilation of human preterm neonates . J Pediatr 1990 ; 117(1): 106-11.

Lachmann B. , Tutuncu AS , Bos Jah , Faithfull NS , Erdmann W. Perflubron (perfluorooctylbromide) instillation combined with mechanical ventilation: an alternative treatment of acute respiratory failure in adult animals. In: Erdmann W , Bruley DF eds. Oxygen Transport to Tissue XIV. Advances in Experimental Medicine and Biology, Volume 317. New York: Plenum Press, 1992: 409-12.

Tutuncu AS , Akpir K. , Mulder P. , Erdmann W. , Lachmann B. Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome. Anesthesiology 1993; 79(5): 1083-93.

Curtis SE , Peek JT , Kelly DR Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 1993 ; 75(6): 2696-702.

Lowe Leach C. , Fuhrman BP , Morin III FC , Rath MG Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respiratory distress syndrome: a prospective, randomized, controlled study. Crit Care Med 1993; 21(9): 1270-278.

Richman PS , Wolfson MR , Shaffer TH Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med 1993; 21(5): 768-74.

Menasche P. , Pinard E. , Desroches A-M. et al. Fluorocarbons: a potential treatment of cerebral air embolism in open-heart surgery. Ann Thorac Surg 1985; 40(5): 494-97.

Spiess BD , Braverman B. , Woronowicz AW , Ivankovich AD Protection from cerebral air emboli with perfluorocarbons in rabbits . Stroke 1986; 17: 1146-49.

Menasche P. , Fleury JP , Piwnica A. 1985: Fluorocarbons: a potential treatment of cerebral air embolism in open-heart surgery. 1992 update. Ann Thorac Surg 1992 ; 54(2): 392-93.

Tuman KF , Spiess BD , McCarthy RJ , Ivankovich AD Cardiorespiratory effects of venous air embolism in dogs receiving perfluorocarbon emulsion. J Neurosurg 1986 ; 65: 238-44.

Novotny JA , Bridgewater Bjm , Himm JF , Homer LD Quantifying the effect of intravascular perfluorocarbon on xenon elimination from canine muscle . J Appl Physiol 1993; 74(3): 1356-60.

Mattrey RF , Scheible FW , Gosink BB , Leopold GR , Long DM , Higgins CB Perfluorooctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. Radiology 1982; 145: 759-62.

Mattrey RF Sonographic enhancement of Doppler signals and perfused tissues with perfluorooctylbromide. Investig Radiol 1990; 25 (suppl 1): S158-59.

Andre MP , Steinbach G. , Mattrey RF Enhancement of the echogenicity of flowing blood by the contrast agent perflubron . Investig Radiol 1993; 28(6): 502-506.

Coley BD , Trambert MA , Mattrey RF Perfluorocarbon-enhanced sonography: value in detecting acute venous thrombosis in rabbits. Am J Roentgenol 1994 ; 163: 961-64.

Mattrey RF , Andre MP Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. Am J Cardiol 1984; 54: 206-10.

Mattrey RF , Andre M. , Campbell J. et al. Specific enhancement of intra-abdominal abscesses with perfluorooctylbromide for CT imaging. Investig Radiol 1984; 19(5): 438-46.

Mattrey RF , Brown JJ , Shelton RE , Ogino MT , Johnson KK , Mitten RM Use of perfluorooctylbromide (PFOB) to detect liver abscesses with CT: safety and efficacy. Investig Radiol 1991; 26(9): 792-98.

Coley BD , Mattrey RF , Mitten RM , Peterson T. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB. Investig Radiol 1990; 25(12): 1287-93.

Mattrey RF , Hajek PC , Gylys-Morin VM et al. Perfluorchemicals as gastrointestinal contrast agents for MR Imaging. Preliminary studies in rats and humans. Am J Roentgenol 1987; 148: 1259-63.

Brown JJ , Duncan JR , Heiken JP et al. Perfluorooctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991; 181(2): 455-60.

Judd RM , Rottman GA , Forder JR , Yin FC , Blackband SJ Feasibility of 19F imaging of perfluorochemical emulsions to measure myocardial vascular volume. Magn Reson Med 1992; 28(1): 129-36.

Mason RP , Jeffrey FM , Malloy CR , Babcock EE , Antich PP A noninvasive assessment of myocardial oxygen tension: 19F NMR spectroscopy of sequestered perfluorocarbon emulsion. Magn Reson Med 1992; 27(2): 310-17.

Teicher BA Use of perfluorochemical emulsions in cancer therapy. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 875-82.

Lee I. , Cunningham WP , Levitt SH Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%. Internat J Radiation Biol 1991; 60(4): 695-705.

Holden SA , Teicher BA , Ha C. , Ara G. , Herman TS Enhancement by perfusion emulsion (Oxygent (R)) and carbogen breathing of the tumour growth delay of the FSAIIC fibrosarcoma after treatment with antitumor alkylating agents. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 895-98.

Teicher BA , Herman TS , Menon K. Enhancement of fractionated radiation therapy by an experimental concentrated Perflubron emulsion (Oxygent(R)) in the Lewis lung carcinoma. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 899-902.

Vitu-Loas L. , Thomas C. , Chavaudra N. , Guichard M. Radiosensitivity, blood perfusion and tumour oxygenation after perflubron emulsion injection . Radiother Oncol 1993; 27(2): 149-55.

Berebbaum MC , Akande SL , Armstrong FH et al. Perfluorochemicals and photodynamic therapy in mice. Adv Exp Med Biol 1990; 277: 277-82.

Evans RG , Kimler BF , Moranz RA et al. Phase I/II study of the use of Fluosol DA-20% as an adjuvant to radiation in the treatment of primary high-grade brain tumors. Internat J Rad Oncol Biol Phys 1990; 19: 415-20.

Lustig R. , McIntosh-Lowe N. , Rose C. et al. Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. Internat J Rad Oncol Biol Phys 1989; 16(6): 1587-93.

Dowling S. , Fischer JJ , Rockwell S. Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 903-5.

Rockwell S. , Keley M. , Irvin CG et al. Preclinical evaluation of Oxygent (TM) as an adjunct to radiotherapy. Biomater, Artif Cells Immobilization Biotechnol 1992; 20(2-4): 883-93.

Padilla F. , Wear JO , Van Wagner WH. Effect of fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: in vitro studies. Fed Proc 1975; 34(6):1510-12.

Reindorf CA , Thompson NE In vitro study of the rheological effect of mixtures of trifluorotributylamine (FC43) and Stroma Free Hemoglobin (SFH) on sickled erythrocytes. In: Chang TMS ed. Blood substitutes. New York: Marcel Dekker Inc, 1989 : 675-77.

Ju L-K. , Armiger WB Use of perfluorocarbon emulsions in cell culture . Biotechniques 1992; 12(2): 258-63.

Chang S. Perfluorocarbon liquids in vitreoretinal surgery. International Ophthalmol Clin 1992; 32(2): 153-63.